Search for: "Various John Doe Companies" Results 1321 - 1340 of 2,105
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Nov 2008, 3:42 pm
Securities and Exchange Commission (who now is a board member at RiskMetrics Group), has stated, "If a country does not have a reputation for strong corporate governance practices, capital will flow elsewhere. [read post]
11 Aug 2024, 9:01 pm by renholding
”[15]  The Commission also said that “the fact that a registrant is exposed to a material transition risk does not necessarily result in its … emissions being de facto material to the registrant. [read post]
29 Feb 2016, 4:43 pm by Kevin LaCroix
  With respect to the first basis for liability, the Supreme Court agreed with the company that a statement of opinion or belief does not qualify as a misstatement simply because it is or later proves to be erroneous. [read post]
5 Oct 2011, 6:55 am by Conor McEvily
  Cronkite News has coverage of the oral argument, as does Crime and Consequences. [read post]
22 Mar 2007, 11:13 pm
Does this mean their insured won't also be able to write an article? [read post]
16 May 2016, 8:46 am by Lyle Denniston
The Court acted through a per curiam (“by the Court”) opinion — announced in the Courtroom by Chief Justice John G. [read post]
27 Apr 2020, 1:19 pm by Ronald Mann
That does not suggest to the majority that it should treat all state-created works as copyrightable. [read post]
6 Feb 2007, 4:01 pm
What content do various student audiences need to complicate their thinking? [read post]
15 Nov 2010, 9:58 am by Venkat
Other coverage: John Levine: "How Now to Get Your Email Delivered" The Magill Report: "Email Marketer Sues Microsoft, Yahoo, Return Path, Cisco Ironport" Al Iverson: "Holomaxx suing Microsoft, others" & "Holomaxx Link Roundup" TechEye: "Holomaxx sues Microsoft over mass emailing ban" Topically related posts: "Internet Access Provider & Blocklist Publishers Denied 230(c)(2) Immunity for Anti-Spam Efforts"… [read post]
15 Apr 2011, 11:53 am by Christopher H. Blaszkowski
But this lone justification does not adequately convey the host of interests on the table, nor does it seem to acknowledge the complicated transactional relationships existing in the music industry. [read post]
14 Sep 2011, 12:07 pm by Peter Rost
Rost, a former Pfizer vice president who turned whistleblower after he alleged that a subsidiary of the company started promoting off-label uses of various drugs, not only is in the running for FDA commissioner, but he has at least two congressmen in his corner.This week, the Web site Pharmalot reported that U.S. [read post]
14 Sep 2011, 12:08 pm by Peter Rost
Rost, a former Pfizer vice president who turned whistleblower after he alleged that a subsidiary of the company started promoting off-label uses of various drugs, not only is in the running for FDA commissioner, but he has at least two congressmen in his corner.This week, the Web site Pharmalot reported that U.S. [read post]
30 May 2012, 1:37 pm by Peter Rost
Rost, a former Pfizer vice president who turned whistleblower after he alleged that a subsidiary of the company started promoting off-label uses of various drugs, not only is in the running for FDA commissioner, but he has at least two congressmen in his corner.This week, the Web site Pharmalot reported that U.S. [read post]
2 Oct 2010, 8:43 am by Peter Rost
Rost, a former Pfizer vice president who turned whistleblower after he alleged that a subsidiary of the company started promoting off-label uses of various drugs, not only is in the running for FDA commissioner, but he has at least two congressmen in his corner.This week, the Web site Pharmalot reported that U.S. [read post]
22 Jun 2011, 7:09 am by Peter Rost
Rost, a former Pfizer vice president who turned whistleblower after he alleged that a subsidiary of the company started promoting off-label uses of various drugs, not only is in the running for FDA commissioner, but he has at least two congressmen in his corner.This week, the Web site Pharmalot reported that U.S. [read post]
15 Feb 2012, 7:42 am by Peter Rost
Rost, a former Pfizer vice president who turned whistleblower after he alleged that a subsidiary of the company started promoting off-label uses of various drugs, not only is in the running for FDA commissioner, but he has at least two congressmen in his corner.This week, the Web site Pharmalot reported that U.S. [read post]
14 Sep 2011, 12:07 pm by Peter Rost
Rost, a former Pfizer vice president who turned whistleblower after he alleged that a subsidiary of the company started promoting off-label uses of various drugs, not only is in the running for FDA commissioner, but he has at least two congressmen in his corner.This week, the Web site Pharmalot reported that U.S. [read post]
11 Feb 2011, 7:51 am by Peter Rost
Rost, a former Pfizer vice president who turned whistleblower after he alleged that a subsidiary of the company started promoting off-label uses of various drugs, not only is in the running for FDA commissioner, but he has at least two congressmen in his corner.This week, the Web site Pharmalot reported that U.S. [read post]
9 Sep 2011, 8:40 am by Peter Rost
Rost, a former Pfizer vice president who turned whistleblower after he alleged that a subsidiary of the company started promoting off-label uses of various drugs, not only is in the running for FDA commissioner, but he has at least two congressmen in his corner.This week, the Web site Pharmalot reported that U.S. [read post]
14 Sep 2011, 12:08 pm by Peter Rost
Rost, a former Pfizer vice president who turned whistleblower after he alleged that a subsidiary of the company started promoting off-label uses of various drugs, not only is in the running for FDA commissioner, but he has at least two congressmen in his corner.This week, the Web site Pharmalot reported that U.S. [read post]